Sign Up Today and Learn More About K Health Stock
Invest in or calculate the value of your shares in K Health or other pre-IPO companies through EquityZen's platform.
About K Health Stock
Founded
2016
Headquarters
New York, NY, US
Notable Investor
Bessemer Venture Partners
Industries
K Health is a data-driven digital primary care app that uses AI to deliver personalized primary care. The AI-powered health platform integrates data and creates a predictive model to enable its user to learn more about their personal wellbeing as well as help them better manage their health by comparing themselves to people with similar characteristics–gender, age, symptoms, medical history –through a free symptom tracker.
K Health is backed by Mangrove, 14W, Comcast Ventures, Lerer Hippeau, Primary Ventures, Max Ventures, The Box Group, GGV Capital, Valor Equity Partners, Kaiser Permanente, LTS Ventures, Atreides Ventures, PICO Partners, Marcy Venture Partners, and other New York and Israeli seed investors. It was founded in 2016 by Adam Singolda, Allon Bloch, Israel Roth, and Ran Shaul and is based in New York, New York.
K Health Press Mentions
Stay in the know about the latest news on K Health
Share Of Funding To App Startups Hit Lowest Point In A Decade
news • Dec, 15 2023
Most Active US Investors: Alumni Ventures Leads Cool Month
news • Aug, 4 2023
AI personalized care co K Health raises $59m
en • Jul, 23 2023
The Week’s 10 Biggest Funding Rounds: Smile Doctors Likely Happy With $550M Raise
news • Jul, 21 2023
Israeli Unicorn K Health Raiss Another $59 Million
jewishbusinessnews • Jul, 19 2023
Investors in K Health
Discover investors in K Health stock and explore their portfolio companies
K Health Management
Leadership team at K Health
Chief Executive Officer
Allon Bloch
Chief Technology Officer
Israel Roth
Join now and verify your accreditation status to gain access to:
- K Health current valuation
- K Health stock price
- Available deals in K Health and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in K Health stock?
Accredited investors can buy pre-IPO stock in companies like K Health through EquityZen funds. These investments are made available by existing K Health shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell K Health stock?
Shareholders can sell their K Health stock through EquityZen's private company marketplace. EquityZen's network includes over 300K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
